Small peptide hormones are usually synthesized as large precursor proteins which undergo tissue specific post-translational modifications and proteolytic cleavages to produce mature bioactive peptides. It is not known what accounts for the tissue specificity of the processing reactions. A number of factors which may be involved include: selective expression of processing enzymes, tissue specific modification of the precursor proteins which would govern cleavage site accessability, and differential compartmentalization of either the protease or the precursor protein. We have sought to study many of these questions with gene transfer techniques. Using recombinant vaccinia virus as a mammalian cell expression vector, we have recently established that the yeast alpha-factor endopeptidase, KEX2, processes mouse proopiomelanocortin (mPOMC) in the mammalian cell. The mPOMC/KEX2 reconstitution system will be fully characterized regarding both the processed peptides as well as the subcellular location of processing. The ability of KEX2 to recognize and cleave another neuroendocrine precursor, human proenkephalin (hPE), will also be studied. The processed peptides generated by KEX2 in vivo will be compared to those generated in vitro. This novel complementation methodology will be used to authenticate the role of a candidate POMC endopeptidase, AtT-20 kallikrein. Secondly, using oligonucleotide-directed site specific mutagenesis, we will determine what role specific sequences and/or post-translational modifications have in the transport, endoproteolytic maturation and secretion of mPOMC in heterologous cell types. Following characterization of the hPE side group modifications, the mutagenesis approach will also be used to determine their role in hPE maturation and secretion. Finally, we will exploit unique features of vaccinia biology to express mutant POMC proteins in the homologous cell environment to determine what role specific sequences and/or post-translational modifications have in the tissue specific processing of POMC. Taken together, this information will provide the foundation for our long term goals of defining the functions of specific protein domains as well as cell factors responsible for the tissue specific generation of different sets of mature hormones from single precursor.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK037274-04
Application #
3236113
Study Section
Endocrinology Study Section (END)
Project Start
1985-12-01
Project End
1992-11-30
Budget Start
1988-12-01
Budget End
1989-11-30
Support Year
4
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Oregon Health and Science University
Department
Type
Overall Medical
DUNS #
009584210
City
Portland
State
OR
Country
United States
Zip Code
97239
Dillon, Stephanie L; Williamson, Danielle M; Elferich, Johannes et al. (2012) Propeptides are sufficient to regulate organelle-specific pH-dependent activation of furin and proprotein convertase 1/3. J Mol Biol 423:47-62
Werneburg, Nathan W; Bronk, Steve F; Guicciardi, Maria Eugenia et al. (2012) Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) protein-induced lysosomal translocation of proapoptotic effectors is mediated by phosphofurin acidic cluster sorting protein-2 (PACS-2). J Biol Chem 287:24427-37
Dikeakos, Jimmy D; Thomas, Laurel; Kwon, Grace et al. (2012) An interdomain binding site on HIV-1 Nef interacts with PACS-1 and PACS-2 on endosomes to down-regulate MHC-I. Mol Biol Cell 23:2184-97
Shinde, Ujwal; Thomas, Gary (2011) Insights from bacterial subtilases into the mechanisms of intramolecular chaperone-mediated activation of furin. Methods Mol Biol 768:59-106
Suwaki, Natsuko; Vanhecke, Elsa; Atkins, Katelyn M et al. (2011) A HIF-regulated VHL-PTP1B-Src signaling axis identifies a therapeutic target in renal cell carcinoma. Sci Transl Med 3:85ra47
Simmen, Thomas; Lynes, Emily M; Gesson, Kevin et al. (2010) Oxidative protein folding in the endoplasmic reticulum: tight links to the mitochondria-associated membrane (MAM). Biochim Biophys Acta 1798:1465-73
Dikeakos, Jimmy D; Atkins, Katelyn M; Thomas, Laurel et al. (2010) Small molecule inhibition of HIV-1-induced MHC-I down-regulation identifies a temporally regulated switch in Nef action. Mol Biol Cell 21:3279-92
You, Huihong; Thomas, Gary (2009) A homeostatic switch in PACS-2 links membrane traffic to TRAIL-induced apoptosis. Cell Cycle 8:2679-80
Aslan, Joseph E; You, Huihong; Williamson, Danielle M et al. (2009) Akt and 14-3-3 control a PACS-2 homeostatic switch that integrates membrane traffic with TRAIL-induced apoptosis. Mol Cell 34:497-509
Youker, Robert T; Shinde, Ujwal; Day, Robert et al. (2009) At the crossroads of homoeostasis and disease: roles of the PACS proteins in membrane traffic and apoptosis. Biochem J 421:1-15

Showing the most recent 10 out of 71 publications